Siren Biotechnology
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy. We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Siren Biotechnology
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- LK
Lauren Kelly
Associate Director of in Vivo Pharmacology · Research & Development
EmailPhone - AK
Akela Kuwahara
Chief of Staff · Operations
EmailPhone - NC
Nathalie Clement
SVP, Vector Development · Other
EmailPhone - NK
Nicole K. Paulk
CEO, Founder, President · Other
EmailPhone
Showing 4 of 4 verified contacts
Top roles at Siren Biotechnology
4 distinct titles indexed · top 4 shown.
- 1associate director of in vivo pharmacology
- 1ceo, founder, president
- 1chief of staff
- 1svp, vector development
Sign up to unlock all 4 contacts at Siren Biotechnology
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Siren Biotechnology
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.